Michael Jensen, MD

faculty member

Michael Jensen, MD

Clinical Research Division, Fred Hutch

Fax: 206.667.7983
Mail Stop: D3-100

Dr. Michael Jensen is developing personalized immunotherapies for young patients with cancer. Specifically, he studies an approach called T-cell therapy. In this strategy, T cells — a type of immune cell — are genetically reprogrammed in a lab to target a patient’s cancer cells. Then, they are returned to the patient’s body to kill the tumor cells. His goal is to provide cures for children with cancer without the debilitating side effects of today’s chemotherapies or radiation. Dr. Jensen and colleagues conduct clinical trials of experimental T-cell strategies they created for pediatric patients with leukemia and lymphoma. They continue to refine these approaches while crafting T-cell therapies for young patients with other forms of cancer. Dr. Jensen directs the Ben Towne Center for Childhood Cancer at Seattle Children’s Research Institute.

Other Appointments & Affiliations

Director, Ben Towne Center for Childhood Cancer Research
Seattle Children's Research Institute

Janet and Jim Sinegal Endowed Chair in Pediatric Solid Tumor Research in honor of Korey Rose
Seattle Children's Research Institute

Professor, Pediatrics, Division of Hematology and Oncology
University of Washington School of Medicine


MD, University of Pennsylvania School of Medicine

Pediatric Hematology and Oncology, University of Washington/Fred Hutchinson Cancer Research Center

Find A Clinical Trial

For the Media

The Media Relations team at Fred Hutch is available to assist members of the news media who would like to arrange interviews with faculty.

Email media@fredhutch.org or call 206.667.2210